Cognitive effects of risperidone augmentation in resistant depression

被引：0
|
作者：
Canuso, CM
Pandina, GJ
Bossie, C
Gharabawi, G
Young, AH
Greenspan, A
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S337 / S338
页数：2
相关论文
共 50 条
  • [21] Amisulpride augmentation in treatment resistant depression
    Chang, L. L.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 189 - 189
  • [22] AUGMENTATION STRATEGIES IN TREATMENT RESISTANT DEPRESSION
    Bauer, M.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [23] Augmentation in treatment-resistant depression
    McIntyre, J.
    Moral, Ma Angels
    DRUGS OF THE FUTURE, 2006, 31 (12) : 1069 - 1081
  • [24] Cognitive improvement in schizophrenia and schizoaffective disorder by augmentation of risperidone with galantamine
    Schubert, MH
    Young, KA
    Justice, SB
    Durgam, SK
    Schmitz, WM
    House, MD
    Hicks, PB
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 503 - 503
  • [25] Erratum: Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation
    Mark Hyman Rapaport
    Georges M Gharabawi
    Carla M Canuso
    Ramy A Mahmoud
    Martin B Keller
    Cynthia A Bossie
    Ibrahim Turkoz
    Robert A Lasser
    Amy Loescher
    Philippe Bouhours
    Fiona Dunbar
    Charles B Nemeroff
    Neuropsychopharmacology, 2007, 32 : 1208 - 1208
  • [26] Erratum: Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation
    Mark Hyman Rapaport
    Georges M Gharabawi
    Carla M Canuso
    Ramy A Mahmoud
    Martin B Keller
    Cynthia A Bossie
    Ibrahim Turkoz
    Robert A Lasser
    Amy Loescher
    Philippe Bouhours
    Fiona Dunbar
    Charles B Nemeroff
    Neuropsychopharmacology, 2006, 31 (11) : 2514 - 2514
  • [27] 'Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation.'
    Carroll, Bernard J.
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (10) : 2546 - 2547
  • [28] ‘Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation.’
    Bernard J Carroll
    Neuropsychopharmacology, 2008, 33 : 2546 - 2547
  • [29] Augmentation with risperidone in resistant depression (ARISe-RD): Maintenance of remission in a double-blind placebo controlled trial
    Gharabawi, G
    Mahmoud, R
    Bossie, C
    Turkoz, I
    Loescher, A
    Canuso, C
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S163 - S163
  • [30] Scopolamine augmentation for depressive symptoms and cognitive functions in treatment-resistant depression: A case series
    Fang, Yu
    Guo, Ping
    Lv, Liang
    Feng, Min
    Wang, Hong
    Sun, Guilan
    Wang, Shikai
    Qian, Mincai
    Chen, Huanxin
    ASIAN JOURNAL OF PSYCHIATRY, 2023, 82
12345